Page 3 - Per Persson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Per persson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Per Persson Today - Breaking & Trending Today

Investegate |Acarix AB Announcements | Acarix AB: Positive preliminary data from Acarix's exploratory heart failure study SEISMO

Positive preliminary data from Acarix’s exploratory heart failure study SEISMO
Acarix AB (publ) today announced positive preliminary data from the exploratory SEISMO study, using its modified CADScor
®System on a potential heart failure application.
The SEISMO trial was initiated in June 2018 to evaluate the possibility of developing an algorithm that can differentiate patients referred with suspicion of heart failure. The study, with in total 199 patients at two sites in Denmark, included the last patient in 2020.
Completing the inclusion to the exploratory heart failure study was a great milestone for all involved. The new data looks promising for early heart failure rule out and will be important for all affected patients today waiting all too long for a final diagnosis. The data could warrant a follow-up study to consolidate findings and bring more data for algorithm development,” said Professor Peter Søgaard, MD and primary investigator. ....

Acarix Cadscor , Drug Administration , Per Persson , Real Life Data , Nasdaq First North Premier Growth Market , Certified Adviser , Investegate Announcements , Investegate Company Announcements , Acarix Ab , Globe Newswire , Globenewswire And , ஒன்றுக்கு பெர்சன் , ரியல் வாழ்க்கை தகவல்கள் , நாஸ்டாக் முதல் வடக்கு ப்ரிமியர் வளர்ச்சி சந்தை ,

Acarix AB: Positive preliminary data from Acarix's exploratory heart failure study SEISMO

Acarix AB: Positive preliminary data from Acarix s exploratory heart failure study SEISMO
Positive preliminary data from Acarix s exploratory heart failure study SEISMO
Acarix AB (publ) today announced positive preliminary data from the exploratory SEISMO study, using its modified CADScor
System on a potential heart failure application.
The SEISMO trial was initiated in June 2018 to evaluate the possibility of developing an algorithm that can differentiate patients referred with suspicion of heart failure. The study, with in total 199 patients at two sites in Denmark, included the last patient in 2020.
Completing the inclusion to the exploratory heart failure study was a great milestone for all involved. The new data looks promising for early heart failure rule out and will be important for all affected patients today waiting all too long for a final diagnosis. The data could warrant a follow-up study to consolidate findings and bring more data for algorithm d ....

Drug Administration , Per Persson , Real Life Data , Nasdaq First North Premier Growth Market , Certified Adviser , ஒன்றுக்கு பெர்சன் , ரியல் வாழ்க்கை தகவல்கள் , நாஸ்டாக் முதல் வடக்கு ப்ரிமியர் வளர்ச்சி சந்தை ,